Equities

Genus PLC

GNS:LSE

Genus PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)2,090.00
  • Today's Change-20.00 / -0.95%
  • Shares traded71.78k
  • 1 Year change-2.25%
  • Beta0.3217
Data delayed at least 20 minutes, as of Oct 31 2024 16:35 BST.
More ▼

IC View

The last IC recommendation on Genus PLC shares was Hold at 1,734.00 on 05 Sep 2024Read the full article

Key statistics

On Thursday, Genus PLC (GNS:LSE) closed at 2,090.00, -12.11% below its 52-week high of 2,378.00, set on Jan 26, 2024.
52-week range
Today
1,477.83Feb 15 20242,378.00Jan 26 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open2,100.00
High2,125.00
Low2,080.00
Bid1,630.00
Offer2,175.00
Previous close2,110.00
Average volume66.61k
Shares outstanding66.03m
Free float65.54m
P/E (TTM)177.88
Market cap1.39bn GBP
EPS (TTM)0.1186 GBP
Annual div (ADY)32.00 GBX
Annual div yield (ADY)1.52%
Div ex-dateFeb 29 2024
Div pay-dateMar 28 2024
Next div ex-dateNov 07 2024
Next div pay-dateDec 06 2024
Data delayed at least 20 minutes, as of Oct 31 2024 16:35 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.